Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Best overall response</td><td class="align_center">No. (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Complete response</td><td class="align_center">3 (4)</td></tr><tr><td class="align_left">Partial response</td><td class="align_center">12 (16)</td></tr><tr><td class="align_left">Overall response</td><td class="align_center">15 (20)</td></tr><tr><td class="align_left">Stable disease</td><td class="align_center">31 (41)</td></tr><tr><td class="align_left">Progressive disease</td><td class="align_center">27 (36)</td></tr><tr><td class="align_left">Not evaluable or not assessed</td><td class="align_center">2 (3)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Sarcoma

tab2

Table 2

Table 2: Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution 

Table 2 | Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution 